Constellation Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$3.3M Buy
65,284
+1,048
+2% +$51.3K 0.6% 36
2015
Q4
$3.24M Buy
64,236
+733
+1% +$37K 0.61% 37
2015
Q3
$2.99M Sell
63,503
-104
-0.2% -$5.53K 0.62% 35
2015
Q2
$3.46M Buy
63,607
+628
+1% +$35.2K 0.66% 32
2015
Q1
$3.45M Buy
62,979
+2,411
+4% +$137K 0.66% 29
2014
Q4
$3.28M Buy
60,568
+1,886
+3% +$105K 0.67% 30
2014
Q3
$3.32M Buy
58,682
+315
+0.5% +$17.7K 0.74% 28
2014
Q2
$3.22M Buy
58,367
+628
+1% +$34.3K 0.75% 26
2014
Q1
$3.13M Buy
57,739
+1,468
+3% +$76K 0.76% 27
2013
Q4
$2.69M Buy
56,271
+4,087
+8% +$187K 0.68% 31
2013
Q3
$2.37M Buy
52,184
+1,467
+3% +$67K 0.73% 30
2013
Q2
$2.25M Buy
+50,717
New +$2.27M 0.78% 29

Other funds holding MRK

Constellation Investments's MRK Position: Q1 2016 in Review

Constellation Investments increased its Merck (MRK) stake by 1.6% in Q1 2016, buying an estimated $51.3K and bringing the position to 65,284 shares worth $3.3M. The position accounts for 0.6% of the portfolio, ranked #36.

Constellation Investments first reported a position in MRK in Q2 2013 and has held it in 12 quarters since. The position peaked at $3.46M in Q2 2015. 1,744 funds tracked by Wall St. Rank hold MRK as of Q1 2016.

  • Constellation Investments held 65,284 shares of Merck worth $3.3M as of Q1 2016.
  • Constellation Investments bought 1,048 Merck shares in Q1 2016, an estimated $51.3K.
  • Merck made up 0.6% of Constellation Investments's portfolio in Q1 2016, its #36 holding.
  • Constellation Investments first reported a position in Merck in Q2 2013 and has held it in 12 quarters since.
  • Constellation Investments's Merck position peaked at $3.46M in Q2 2015.
  • 1,744 funds tracked by Wall St. Rank held Merck as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.